Autolus Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.About AUTL
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.
AUTL Key Statistics
AUTL News
Image source: The Motley Fool. Thursday, May 14, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Christian Itin Chief Financial Officer — Robe...
Earnings Call Insights Autolus reiterates $120M-$135M 2026 AUCATZYL revenue guidance as it targets 65%-70% peak ALL gross margin May 14, 2026, 8:11 PM ET Autolu...
Reports Q1 revenue $26.22M, consensus $26.13M. “In the first quarter, Autolus continued to expand market share for AUCATZYL in the US based on strong physician...
Analyst ratings
91%
of 11 ratingsMore AUTL News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.